Skip to main content

Hormone Replacement Therapy in Menopause

  • Chapter
  • First Online:
Book cover Ambulatory Gynecology

Abstract

Vasomotor and vaginal symptoms are the hallmark symptoms of menopause. The reported prevalence of vasomotor symptoms is 50–82% in women who experience natural menopause. The occurrence of symptoms increases during perimenopause and usually peaks at the actual onset of menopause.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. ACOG Practice Bulletin 141, January 2014 (Reaffirmed 2016): Management of menopausal symptoms.

    Google Scholar 

  2. ACOG Practice Bulletin 126, March 2012: Management of gynecological issues in women with breast cancer.

    Google Scholar 

  3. Position Statement: The 2017 Hormone Therapy Position Statement of the North American Menopause Society.

    Google Scholar 

  4. ACOG Committee Opinion, August 2012: Compounded bioidentical menopausal hormone therapy.

    Google Scholar 

  5. Global Consensus on Menopausal Hormone Therapy, 2013: International menopause society and the European menopause and andropause society.

    Google Scholar 

  6. Executive Summary: Postmenopausal Hormone Therapy: An Endocrine Society Scientific Statement 2010.

    Google Scholar 

  7. Manson J, et al. Menopausal hormone therapy and health outcomes during the intervention and extended post stopping phases of the women’s health initiative randomized trials. JAMA. 2013;310(13):1353–68. https://doi.org/10.1001/jama.2013.278040.

    Article  CAS  PubMed  Google Scholar 

  8. ACOG Committee Opinion 2013 (Reaffirmed 2015): postmenopausal estrogen therapy: route of administration and risk of VTE.

    Google Scholar 

  9. KEEPS Report, NAMS 2012 Meeting. www.menopause.org.

  10. Manson, Kaunitz NEJM 2016 Menopause management-getting clinical care back on track.

    Google Scholar 

  11. Hormone Therapy and Alternative Therapies for Menopause, ACOG: Clinical Updates in Women’s Health Care. Volume XIV, Number 4., October 2015

    Google Scholar 

  12. Harman, American College of Physicians et al. 2014 Arterial imaging outcome and cardiovascular risk factors in recently menopausal women: a randomized trial.

    Google Scholar 

  13. Uptodate.com, Preparations for menopausal hormone therapy.

    Google Scholar 

  14. ACOG Committee Opinion 2016, The use of vaginal estrogen in women with a history of estrogen dependent breast cancer.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Edward S. Linn MD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Science+Business Media, LLC, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Linn, E.S., Weyl, L. (2018). Hormone Replacement Therapy in Menopause. In: Knaus, J., Jachtorowycz, M., Adajar, A., Tam, T. (eds) Ambulatory Gynecology. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-7641-6_15

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-7641-6_15

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-7639-3

  • Online ISBN: 978-1-4939-7641-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics